Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03272139Phase 4Completed
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Hospital for Special Surgery. Primary endpoints: Hemidiaphragmatic Paralysis and Numerical Pain Rating System. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03272139.